These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Short term efficacy of methotrexate in the treatment of rheumatoid arthritis. Willkens RF J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():21-4. PubMed ID: 3913772 [TBL] [Abstract][Full Text] [Related]
23. The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Belinsky GS; Parke AL; Huang Q; Blanchard K; Jayadev S; Stoll R; Rothe M; Achenie LE; Gupta RR; Wu GY; Rosenberg DW Toxicol Sci; 2007 Jun; 97(2):582-94. PubMed ID: 17400583 [TBL] [Abstract][Full Text] [Related]
24. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Prey S; Paul C Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303 [TBL] [Abstract][Full Text] [Related]
25. The clinical pharmacology of methotrexate: new applications of an old drug. Bleyer WA Cancer; 1978 Jan; 41(1):36-51. PubMed ID: 342086 [TBL] [Abstract][Full Text] [Related]
27. [Reducing toxicity of methotrexate with folic acid]. Harten P Z Rheumatol; 2005 Jun; 64(5):353-8. PubMed ID: 15965822 [TBL] [Abstract][Full Text] [Related]
28. Etanercept: new preparation. Useful after methotrexate failure in inflammatory rheumatism. Prescrire Int; 2003 Aug; 12(66):127-32. PubMed ID: 12906020 [TBL] [Abstract][Full Text] [Related]
29. Methotrexate pharmacokinetics in psoriatic patients developing hepatic fibrosis. Jones SK; Aherne GW; Campbell MJ; White JE Arch Dermatol; 1986 Jun; 122(6):666-9. PubMed ID: 3717976 [TBL] [Abstract][Full Text] [Related]
30. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study. Bjerring P; Beck HI; Zachariae H; Søgaard H Acta Derm Venereol; 1986; 66(6):515-9. PubMed ID: 2433872 [TBL] [Abstract][Full Text] [Related]
31. [Chinese expert-based consensus for methotrexate in rheumatic diseases]. Chinese Association of Rheumatology and Immunology Physicians Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):719-722. PubMed ID: 30293331 [TBL] [Abstract][Full Text] [Related]
38. Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent? Tariq S; Tariq SM Postgrad Med J; 1993 Oct; 69(816):775-80. PubMed ID: 8290407 [No Abstract] [Full Text] [Related]
39. Insights on methotrexate in psoriatic disease. Greb JE; Goldminz AM; Gottlieb AB Clin Immunol; 2016 Nov; 172():61-64. PubMed ID: 27455859 [TBL] [Abstract][Full Text] [Related]